https://www.selleckchem.com/products/arv-825.html
Recurrent hyperkalaemia may result in underutilisation of renin-angiotensin-aldosterone system inhibitors. We report an analysis of French data from the PROKALE retrospective study, which assessed the management of recurrent hyperkalaemia in five European countries. A retrospective chart review including patients not on dialysis with two or more hyperkalaemia episodes≥5.5mEq/L documented within a 12-month observation period was performed. In France, 115physicians (57nephrologists et 58cardiologists) participated in the study and 295pati
Like
Comment
Share
